RO60 and arthritic joint disease: Besides, the overlap between high IFN activity and IFN-γ was observed among patients with arthritis (27%) and low complement (25%) and carrying anti-dsDNA (16%), anti-Sm (33%) or anti-Ro60 (17.5%) antibodies (Additional file 1: Figure S2).